Material Agreement Form 8 K

Item 1.01. Entry into a Material Definitive Agreement.

On June 26, 2024, our wholly-owned subsidiary, Silo Pharma, Inc., a Florida corporation, entered into a Fourth Amendment to Master License Agreement (the "Fourth Amendment") with the University of Maryland, Baltimore, pursuant to which the parties agreed to an amended and restated schedule of diligence milestones for the Master License Agreement.

The foregoing description of the Fourth Amendment does not purport to be complete and is qualified in its entirety by reference to the Fourth Amendment, which is attached hereto as Exhibit 10.1 and is incorporated herein by reference.